Ophthalmology Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Ophthalmology stocks.

Ophthalmology Stocks Recent News

Date Stock Title
Jun 3 PFE Takeda and Pfizer report positive Phase III HD21 trial of ADCETRIS
Jun 2 PFE Lung Cancer Was a Death Sentence. Now Drugs Are Saving Lives.
Jun 1 PFE GSK, Pfizer must face tens of thousands of Zantac cases in Delaware
Jun 1 PFE 3 Stocks to Buy for Huge Income
Jun 1 PFE Takeda and Pfizer Announce Four-Year Results from Positive Phase 3 HD21 Trial of Additional ADCETRIS® (brentuximab vedotin) Combination in Frontline Hodgkin Lymphoma
Jun 1 PFE Pfizer’s ADCETRIS® Regimen Produces Clinically Meaningful Improvement in Overall Survival in Patients with Relapsed/​Refractory Diffuse Large B-cell Lymphoma (DLBCL)
May 31 PFE Pfizer Reports Encouraging Long-Term Trial Results of Advanced Lung Cancer Drug
May 31 PFE The Most Profitable Biotechnology Company in the World
May 31 PFE Moderna Looks for Boost From Newly Approved RSV Shot
May 31 PFE Moderna Wins FDA Approval For Second-Ever Product; Why Its RSV Vaccine Could Dominate Pfizer, GSK
May 31 PFE Pfizer (PFE) Up 1.8% Since Last Earnings Report: Can It Continue?
May 31 OCGN (OCGN) - Analyzing Ocugen's Short Interest
May 31 REGN FDA Extends Review Deadline For Regeneron/Sanofi's Dupixent For 'Smoker's Lungs' Disease
May 31 PFE Pfizer posts long-term data to support lung cancer therapy Lorbrena
May 31 REGN FDA Delays Decision on Sanofi (SNY)-Regeneron Dupixent in COPD
May 31 OCGN Data and Safety Monitoring Board Approves Simultaneous Enrollment in Cohort 3 and Phase 2 Initiation in OCU410 ArMaDa study for Geographic Atrophy
May 31 PFE Pfizer gene therapy for haemophilia B therapy endorsed in EU
May 31 PFE Pfizer’s LORBRENA® CROWN Study Shows Majority of Patients with ALK-Positive Advanced Lung Cancer Living Beyond Five Years Without Disease Progression
May 31 PFE Moderna wins FDA approval for RSV vaccine
May 31 REGN Regeneron/ Sanofi say FDA has delayed Dupixent COPD label
Ophthalmology

Ophthalmology (, or ) is a branch of medicine and surgery (both methods are used) that deals with the diagnosis and treatment of eye disorders. An ophthalmologist is a specialist in Ophthalmology. Their credentials include a doctorate degree in medicine, followed by an additional four years of Ophthalmology residency training. They may or may not receive residency training in internal medicine, pediatrics, or general surgery before the ophthalmology residency. Additional training may be sought through a fellowship in a particular specialty of eye pathology. Ophthalmologists are allowed to use medications to treat eye diseases, implement laser therapy, and perform surgery when needed. Ophthalmologists may participate in academic research on the diagnosis and treatment for eye disorders.

Browse All Tags